Gene · 4607
NIH grants2,246
NIH grants whose papers are about the gene, through NIH's grant-paper links.
901 to 920 of 2,246
Download this page as JSON| Grant | Title | MYBPC3 papers | Newest fiscal year |
|---|---|---|---|
| R01HG009922 | Experiences and Outcomes in Early Adopters of Predispositional Sequencing | 1 | 2020 |
| R01HL091069 | Pre-DETERMINE: Biologic Markers and MRI SCD Cohort Study | 1 | 2020 |
| R01HL130417 | Human heart-on-a-chip for screening cardiomyopathy and chemotherapeutic cardiotoxicity | 1 | 2020 |
| R01HL130539 | STOP-CA: Statins to prevent Cardiotoxicity from Anthracyclines | 1 | 2020 |
| R01HL131831 | Novel Protein Kinase GI Substrates in Cardiac Remodeling and Blood Pressure Control | 1 | 2020 |
| R01HL132067 | Cellular Remodeling in Heart Failure and after LVAD Unloading | 1 | 2020 |
| R01HL132075 | Mitochondrial Turnover in the Human Heart | 1 | 2020 |
| R01HL132226 | Harnessing Paracrine Mechanisms of Stem Cell-mediated Cardiac Contractile Enhancement | 1 | 2020 |
| R01HL132871 | Pathophysiological Regulation of Atrial Alternans and Atrial Fibrillation | 1 | 2020 |
| R01HL133165 | Genetic Determinants of Chagas Cardiomyopathy | 1 | 2020 |
| R01HL133272 | Molecular Imaging of Cardiac Pluripotent Stem Cells | 1 | 2020 |
| R01HL133832 | AKAP-dependent regulation of Cardiac SR Ca handling | 1 | 2020 |
| R01HL134824 | Defining novel mechanisms for regulation of atrial INa and arrhythmias | 1 | 2020 |
| R01HL134885 | Sleep Apnea and Hypertrophic Cardiomyopathy - Implications for Arrhythmia and Sudden Death | 1 | 2020 |
| R01HL135093 | Therapeutic Mechanisms of Cardiac Progenitors in Ischemic Cardiomyopathy | 1 | 2020 |
| R01HL135358 | Protein quality control, cardiomyopathy, cardiotoxicity and human isogenic iPSCs | 1 | 2020 |
| R01HL135879 | EHR-Based Strategies to Improve Outcomes in Familial Hypercholesterolemia | 1 | 2020 |
| R01HL137100 | Systems Biology of Hypertrophic Heart Disease from Molecular Pathways to Organ System | 1 | 2020 |
| R01HL137562 | Mechanisms of Cardiac Dysfunction in HIV and the Effect of Statins | 1 | 2020 |
| R01NS052738 | Mechanism of regulation of progenitor proliferation and transformation | 1 | 2020 |
Source NIH's project filesgene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4607/grants?page=46